Cephalexin PCD Pharma Franchise Company

Cafoli Lifecare offers a Cephalexin range of 8 formulations across capsules, tablets, dry syrup and suspension, manufactured in WHO-GMP certified facilities. Distributors building an oral-antibiotic portfolio can secure district-wise monopoly franchise rights across this dependable first-line cephalosporin with full promotional support.

What is Cephalexin?

Cephalexin is a first-generation oral cephalosporin antibiotic. It inhibits bacterial cell-wall synthesis and is especially reliable against Gram-positive skin and soft-tissue organisms and common urinary and respiratory pathogens, with a long record of safety including use in children. Reference: PubChem - Cephalexin.

Available Forms

The Cafoli Cephalexin portfolio includes Capsules and Tablets for adults and Dry Syrup and Suspension for paediatric dosing. Contact us for current pack presentations and combinations.

Therapeutic Applications

Cephalexin is prescribed for skin and soft-tissue infections, respiratory tract infections, urinary tract infections, dental infections and bone infections. Prescribers include dermatologists, physicians, paediatricians, dentists, surgeons and general practitioners.

Why Cephalexin is a High-Potential Molecule for Distributors

Cephalexin is a trusted, low-cost first-line antibiotic that dermatologists and GPs reach for routinely in skin and soft-tissue infections, giving it steady everyday prescription volume. Its paediatric syrups broaden the base further, and its safety record and affordability make it an easy, high-turnover staple for a distributor to place across clinics and chemists.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Cephalexin
2. MedlinePlus: Cephalexin
3. WHO Essential Medicines List - cefalexin